Media Database
>
Katie Kalvaitis

Katie Kalvaitis

Editorial Director / Medical Editor & Reporter at Cardiology - Healio

Contact this person
Email address
k*****@*******.comGet email address
Influence score
41
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

healio.com

Evolocumab lowers risk for first major cardiovascular events

NEW ORLEANS — In patients with atherosclerosis and/or diabetes without a prior heart attack or stroke, evolocumab cut the risk for first major adverse CV events by 25% compared with placebo, according to results of the VESALIUS-CV trial.Lowering LDL cholesterol with PCSK9 inhibitors, including evolocumab (Repatha, Amgen), lowers risk for CV events in patients with a prior major
healio.com

Antihypertensive therapy step-down strategy not beneficial for frai...

Progressive discontinuation of antihypertensive medications did not lower risk for mortality compared with usual care among older nursing home residents with frailty, according to results from the RETREAT-FRAIL trial.“RETREAT-FRAIL is the first randomized controlled trial to evaluate the long-term effects of an antihypertensive treatment step-down [strategy] on mortality, morbidity [and]
healio.com

Benefit of beta-blocker therapy after heart attack may depend on he...

Benefit of beta-blocker therapy after heart attack may depend on heart function
healio.com

Remote atrial fibrillation screening with wearable ECG patch confer...

A remote screening strategy for asymptomatic atrial fibrillation involving use of an ECG patch for continuous ambulatory monitoring conferred a modest increase in AF diagnoses after 2.5 years among older adults at risk for stroke.The fully remote, randomized AMALFI trial evaluated long-term efficacy of AF screening via use of a 14-day patch-based continuous ambulatory ECG monitor (Zio XT,
healio.com

Development of heart failure may accelerate cognitive decline in ol...

BOSTON — Older adults who developed incident HF showed acute declines in cognition, memory and executive function, followed by a steep decline in cognitive function in subsequent years, according to results of a prospective cohort study.Although it is known that about 40% to 60% of patients who develop HF may have cognitive impairment, how HF impacts the trajectory of cognitive function and
healio.com

Emerging therapies for lowering Lp(a): ‘Peering into the future’

BOSTON — There are a number of emerging therapies in development for lowering lipoprotein(a), and later-stage trials are underway.Interest continues to grow in lipoprotein(a), commonly known as Lp(a), both as a risk factor for CVD, as well as therapies to lower levels of Lp(a).
healio.com

Misinformation about cholesterol ‘widespread’ on TikTok

BOSTON — Much of the health-related content about cholesterol on social media, in particular TikTok, is inaccurate, according to research presented at the American Society for Preventive Cardiology Congress on CVD Prevention.Due to increasing use of social media to search for health-related content, researchers conducted a study that looked at the top videos on TikTok using the search terms
healio.com

AI could boost detection of familial hypercholesterolemia

AI could boost detection of familial hypercholesterolemia
healio.com

Zimislecel, a novel cell therapy, appears to restore islet function...

CHICAGO — A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and conferred improved outcomes and insulin independence at 1 year in a small study of patients with type 1 diabetes.Results from the phase 1/2 portion of the FORWARD-101 trial, which enrolled patients with type 1 diabetes with severe hypoglycemic events and impaired
healio.com

Dyslipidemia in younger women: Recognize risk, start early with lif...

PHILADELPHIA — Lipid management for woman requires personalized care that considers sex-specific conditions across the reproductive lifespan, particularly during pregnancy, Pam R. Taub, MD, said during the Heart in Diabetes CME Conference. “When we talk about the lifespan of women, we typically focus on lipid management in middle-aged and elderly women; we really don’t focus on
healio.com

Four recent cardiometabolic research updates you should know

PHILADELPHIA — During a session at the Heart in Diabetes CME Conference, speakers highlighted four papers recently published in Circulation that advance the field of cardiometabolic research.“Each year [for Heart in Diabetes], I’ve gleaned the journal to pick four or five of the best papers we’ve published related to diabetes,” Darren K. McGuire, MD, MHSc, deputy